Basilea Pharmaceutica Ltd. is a commercial stage biopharmaceutical company headquartered in Basel, Switzerland and listed on the SIX Swiss Exchange (SIX: BSLN). It focuses on the development of products that address the medical challenges in the therapeutic areas of oncology and anti-infectives.
